MGMT and glioblastoma: The in vitro experiments and the experiments with mice in vivo showed that the combination of VPA and temozolomide enhanced the apoptotic and autophagic cell death, as well as suppressed the migratory activities in temozolomide-resistant glioblastoma cells that express O-(6)-methylguanine-DNA methyltransferase (MGMT).